This inventor holds 2 USPTO granted patents. Top assignee: A. Nattermann & Cie Gmbh. Active years: 1981-1986.
Location History:
- Erftstadt-Lechenich, DE (1981)
- Erftstadt, DE (1986)
Company Filing History:
Years Active: 1981-1986
Title: Innovations of Joachim Uhlendorf
Introduction
Joachim Uhlendorf is a notable inventor based in Erftstadt-Lechenich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, Uhlendorf's work focuses on innovative solutions for treating inflammatory and allergic processes in humans.
Latest Patents
Uhlendorf's latest patents include the invention of 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines. This invention relates to new compounds that possess potential therapeutic benefits. Additionally, he has developed (3-Alkylamino-2-hydroxypropoxy)-furan-2-carboxylic acid anilides, which exhibit β-adrenolytic properties and low toxicity. These compounds are designed to provide effective treatment options for various medical conditions.
Career Highlights
Joachim Uhlendorf is associated with A. Nattermann & Cie GmbH, where he has been instrumental in advancing pharmaceutical research and development. His innovative approach and dedication to improving healthcare solutions have made him a valuable asset to the company.
Collaborations
Uhlendorf has collaborated with notable colleagues, including Harald O Borbe and Sigurd Leyck. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical innovation.
Conclusion
Joachim Uhlendorf's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic options that can improve patient outcomes.